Condition
HIV Positive
ClinicalTrials.gov condition label
Explore related research
Search across original and mapped recordsSearch results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 30 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
30 shownThinking and Memory Problems in People With HIVNCT01875588 · 2013-07-08
RECRUITINGImplementation and Effectiveness of a Psychosocial Intervention Among Registered People Living With HIV(HIV Patients) at Pakistan Institute of Medical Sciences (PIMS) Islamabad Pakistan.NCT06869330 · 2025-03-14
COMPLETEDBone, Inflammation, Gut and Renal Biomarkers in Antiretroviral Naïve HIV-1 Positive SubjectsNCT03660722 · 2023-10-01
WITHDRAWNIndia HIV-CervCa ProjectNCT07167069 · 2021-02-09
COMPLETEDPregnant and Parenting Teens Living With HIV in Lusaka, ZambiaNCT07807670 · 2020-04-17
COMPLETEDAlcohol Research Consortium in HIV-Intervention Research ArmNCT02938377 · 2017-11-06
COMPLETEDAntioxidant in Patients HIV+ Supplemented With Microencapsulated of Red PomegranateNCT03531749 · 2017-01-01
COMPLETEDIMPAACT P1092: Steady State PK in Malnourished HIV Infected ChildrenNCT01818258 · 2015-10-26
COMPLETEDOpen Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve SubjectsNCT02404233 · 2015-03-01
UNKNOWNIntegrated Treatment and Prevention for People Who Inject DrugsNCT02935296 · 2015-02-04
COMPLETEDA Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's SarcomaNCT02029430 · 2014-04-03
COMPLETEDCCTG 594: Engagement and Retention in Care for HIV+NCT01957748 · 2013-10-08
COMPLETEDCCTG 593: Testing and Linkage to CareNCT01941121 · 2013-07-26
COMPLETEDEvaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negative PeopleNCT01904201 · 2013-07-01
TERMINATEDOligonucleotide Ligation Assay (OLA) Resistance StudyNCT01898754 · 2013-05-01
COMPLETEDThe Effects of Ageing on the 'Pharmacokinetic and Clinical Observations in People Over Fifty'NCT01737047 · 2013-04-01
COMPLETEDTransplantation and the Use of Raltegravir in HIV-Infected PatientsNCT01793467 · 2012-10-01
COMPLETEDAssessment of the Effectiveness of New Clinical Guidelines for Differential Diagnosis and Management of Common HIV/AIDS-related Conditions in MozambiqueNCT01681914 · 2012-04-01
COMPLETEDMedical Marijuana Use in HIV+ Patients Prospective Cohort StudyNCT01536899 · 2012-02-01
COMPLETEDMedical Marijuana Use in HIV+ Patients: Probability SurveyNCT01536912 · 2012-02-01
COMPLETEDSafety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral TherapyNCT01365065 · 2011-05-01
UNKNOWNElizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site ProtocolNCT00639145 · 2010-09-01
COMPLETEDRETRIeVE: ReversE TranscRiptase Inhibitor hiV PracticeNCT01154556 · 2010-06-01
COMPLETEDComplementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico BorderNCT01152684 · 2009-09-01
COMPLETEDThe Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist TreatmentNCT00857350 · 2008-06-01
COMPLETEDSafety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital HerpesNCT01154543 · 2008-03-01
COMPLETEDEvaluation of a Human Immunodeficiency Virus (HIV) Blood Screening AssayNCT00686205 · 2007-08-01
COMPLETEDThe Effect of HPV Vaccination on Recurrence Rates in HIV Patients With CondylomataNCT00941889 · 2007-07-01
COMPLETEDRelationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDSNCT00106795 · 2005-03-22
COMPLETEDMeasuring HIV Quality of CareNCT00012701
COMPLETEDCommon interventions
100 mg/m2 aldoxorubicinDRUG1150 mg/m2 aldoxorubicinDRUG150 mg/m2 aldoxorubicinDRUG1blood and urinary samplesOTHER1CBT4CBTBEHAVIORAL1collection of follow-up sample based on PRISM HIV O Plus resultDEVICE1Computerized Brief Intervention (CBI)BEHAVIORAL1darunavir/cobicistatDRUG1HIV+ ascorbic acidDIETARY_SUPPLEMENT1HIV+ MRPJDIETARY_SUPPLEMENT1Integrated InterventionBEHAVIORAL1Linkage to PrEP or CareBEHAVIORAL1P2G comprehensive packageOTHER1Pre-ART Oligonucleotide Assay (OLA)OTHER1psychosocialBEHAVIORAL1Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant VaccineDRUG1Radiation TherapyRADIATION1Recommendation and Counseling for Alcohol PharmacotherapyDRUG1rilpivirineDRUG1SalineDRUG1SoC + ALERT InterventionBEHAVIORAL1VorinostatDRUG1ZDV+3TC+LPV/rDRUG1
Mapped drugs appearing in these trials
Shared trial participation only; not evidence of efficacy or approval.
Leading sponsors
University of California, San Diego
3
Holdsworth House Medical Practice
2
Wayne State University
2
Abbott Diagnostics Division
1
Abramson Cancer Center at Penn Medicine
1
Bayside Health
1
Centre for Infectious Disease Research in Zambia
1
Centre Hospitalier Universitaire de Saint Etienne
1
Duke University
1
Elizabeth Glaser Pediatric AIDS Foundation
1
HIV Prevention Trials Network
1
ImmunityBio, Inc.
1
Imperial College London
1
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
1
National Institute of Allergy and Infectious Diseases (NIAID)
1
Trial status mix
COMPLETED25
UNKNOWN2
RECRUITING1
TERMINATED1
WITHDRAWN1
Phase mix
NA9
PHASE43
PHASE22
PHASE31
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.